Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?

Breast Journal

Volumn 13, Issue 5, 2007, Pages 479-485

  Jayasinghe, Upali W ^a   Bilous, A Michael ^a   Boyages, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast cancer survival; Clinicopathologic characteristics; Infiltrating ductal carcinoma; Infiltrating lobular carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST BIOPSY; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DUCTAL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE;

EID: 34548207096     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00468.x     Document Type: Article

References (34)

1. Ashikari R, Huvos AG, Urban JA, Robbins GF. Infiltrating lobular carcinoma of the breast. Cancer 1973 31 : 110 16.
2. Mate TP, Carter D, Fischer DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer 1986 58 : 1995 2002.
3. Borst MJ, Ingold J. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993 114 : 637 42.
4. Smith DB, Howell A, Wagstaff J. Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. Eur J Cancer Clin Oncol 1987 23 : 979 82.
5. Harris M, Howell A, Chrissohou M, Swindell RIC, Hudson M, Sellwood RA. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984 50 : 23 30.
6. Toikkanen S, Pylkkanen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997 76 : 1234 40.
7. du Toit RS, Locker AP, Ellis IO, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991 17 : 251 57.
8. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 1994 73 : 1673 77.
9. Howell A, Harris M. Infiltrating lobular carcinoma of the breast. Br Med J 1985 291 : 1371 72.
10. Walker Q, Bilous M, Tiver KW, Langlands O. Breast cancer metastases as primary gastric carcinoma. ANZ J Surg 1986 56 : 395 98.
11. Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 2005 21 : 41 48.
12. Jayasinghe UW, Taylor R, Boyages J. Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J Surg 2005 75 : 762 67.
13. Bartelink H, Borger JH, van Dongen JA, Peterse JL. The impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol 1988 11 : 297 303.
14. Gamel JW, Meyer JS, Feuer EJ, Miller BA. Impact of stage and histology on the long-term clinical course of 163,308 patients with breast carcinoma. Cancer 1996 77 : 1459 64.
15. Brightmore TGJ, Greening WP, Hamlin I. An analysis of clinical and histopathological features in 101 cases of carcinoma of breast in women under 35 years of age. Br J Cancer 1970 24 : 644 69.
16. Gray RJ. Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis. J Am Stat Assoc 1992 87 : 942 51.
17. Chevallier B, Mosseri V, Dauce JP, Bastit P, Julien JP, Asselain B. A prognostic score in histological node negative breast cancer. Br J Cancer 1990 61 : 436 40.
18. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980 45 : 2917 24.
19. Bonett A, Dorsch M, Roder D, Esterman A. Infiltrating ductal carcinoma of the breast in South Australia. Implications of trends in tumour diameter, nodal status and case-survival rates for cancer control. Med J Aust 1990 152 : 19 23.
20. Epstein AH, Connolly JL, Gelman R, et al. The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy. Int J Radiat Oncol Biol Phys 1989 17 : 755 60.
21. Freedman LS, Edwards DN, McConnell EM, Downham DY. Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer 1979 40 : 44 55.
22. Gillis CR, Hole DJ. Survival outcomes of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 1996 312 : 145 48.
23. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. JAMA 1994 271 : 1163 68.
24. Carter C, Allen C, Henson D. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989 63 : 181.
25. Berg JW, Hutter RVP. Breast cancer. Cancer 1995 75 : 257 69.
26. Stalsberg H, Thomas DB. Age distribution of histologic types of breast carcinoma. Int J Cancer 1993 54 : 1 7.
27. The Western Areas Breast Group. Breast Cancer Patterns of Care in The Greater Western Region of Sydney in 1992, A NSW Health Outcomes Program Project. Westmead, NSW : The Western Areas Breast Group and the NSW Breast Cancer Institute, 1997.
28. Taylor R, Stubbs JM, Langlands AO, Boyages J. Predictors of mastectomy for women with breast cancer in the greater western region of Sydney. Breast J 1999 5 : 116 21.
29. Taylor R, Davis P, Boyages J. Long-term survival of women with breast cancer in New South Wales. Eur J Cancer 2002 39 : 215 22.
30. Leong C, Boyages J, Jayasinghe UW, et al. Effects of margins on ipsilateral breast tumour recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004 100 : 1823 32.
31. Rutquist LE, Wallgren A. Long-term survival of 458 young breast cancer patients. Cancer 1985 55 : 658 65.
32. Host H, Lund E. Age as a prognostic factor in breast cancer. Cancer 1986 57 : 2217 21.
33. Lee CG, McCormick B, Mazumdar M, Vetto J, Borgen PI. Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors. Int J Radiat Oncol Biol Phys 1992 23 : 969 75.
34. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996 77 : 113 20.